Cantor Fitzgerald upgraded shares of HMS (NASDAQ:HMSY) from a neutral rating to an overweight rating in a report released on Tuesday morning, The Fly reports.
Several other research firms have also issued reports on HMSY. BidaskClub lowered shares of HMS from a buy rating to a hold rating in a research report on Wednesday, January 16th. Zacks Investment Research raised shares of HMS from a hold rating to a buy rating and set a $32.00 price target on the stock in a research report on Wednesday, January 16th. Finally, William Blair reissued an outperform rating on shares of HMS in a research report on Thursday, March 14th. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has a consensus rating of Buy and an average price target of $33.50.
Shares of HMSY stock opened at $28.70 on Tuesday. The stock has a market capitalization of $2.64 billion, a price-to-earnings ratio of 34.17, a P/E/G ratio of 2.84 and a beta of 1.61. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.40 and a current ratio of 4.40. HMS has a 52 week low of $17.11 and a 52 week high of $38.15.
In related news, insider Meredith W. Bjorck sold 2,362 shares of the business’s stock in a transaction that occurred on Monday, April 15th. The shares were sold at an average price of $30.10, for a total transaction of $71,096.20. Following the completion of the transaction, the insider now owns 51,755 shares of the company’s stock, valued at $1,557,825.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Jeffrey Scott Sherman sold 268,426 shares of the business’s stock in a transaction that occurred on Thursday, February 28th. The shares were sold at an average price of $34.55, for a total transaction of $9,274,118.30. Following the transaction, the chief financial officer now directly owns 218,253 shares of the company’s stock, valued at approximately $7,540,641.15. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,018,795 shares of company stock valued at $35,023,853. 4.54% of the stock is owned by corporate insiders.
A number of large investors have recently modified their holdings of the stock. Norges Bank purchased a new position in HMS in the 4th quarter worth approximately $42,907,000. Oregon Public Employees Retirement Fund purchased a new position in HMS in the 4th quarter worth approximately $32,000. FMR LLC purchased a new position in HMS in the 3rd quarter worth approximately $27,949,000. Deutsche Bank AG grew its stake in HMS by 140.3% in the 4th quarter. Deutsche Bank AG now owns 852,553 shares of the business services provider’s stock worth $23,979,000 after buying an additional 497,695 shares in the last quarter. Finally, Standard Life Aberdeen plc grew its stake in HMS by 45.5% in the 3rd quarter. Standard Life Aberdeen plc now owns 1,542,251 shares of the business services provider’s stock worth $50,578,000 after buying an additional 482,126 shares in the last quarter. 95.47% of the stock is owned by institutional investors.
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.
See Also: Consumer behavior in bull markets
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.